# Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects

> **NCT00388609** · PHASE2 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 705 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** BMS-646256
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00388609
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2007-09
- **Final completion:** 2009-04
- **Target enrollment:** 705 (ACTUAL)
- **Last updated:** 2010-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00388609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00388609, "Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00388609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*